Correlation Between Ovid Therapeutics and XOMA
Can any of the company-specific risk be diversified away by investing in both Ovid Therapeutics and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ovid Therapeutics and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ovid Therapeutics and XOMA Corporation, you can compare the effects of market volatilities on Ovid Therapeutics and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ovid Therapeutics with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ovid Therapeutics and XOMA.
Diversification Opportunities for Ovid Therapeutics and XOMA
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ovid and XOMA is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Ovid Therapeutics and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Ovid Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ovid Therapeutics are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Ovid Therapeutics i.e., Ovid Therapeutics and XOMA go up and down completely randomly.
Pair Corralation between Ovid Therapeutics and XOMA
Given the investment horizon of 90 days Ovid Therapeutics is expected to generate 21.26 times more return on investment than XOMA. However, Ovid Therapeutics is 21.26 times more volatile than XOMA Corporation. It trades about 0.03 of its potential returns per unit of risk. XOMA Corporation is currently generating about -0.21 per unit of risk. If you would invest 113.00 in Ovid Therapeutics on September 1, 2024 and sell it today you would earn a total of 1.00 from holding Ovid Therapeutics or generate 0.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ovid Therapeutics vs. XOMA Corp.
Performance |
| Timeline |
| Ovid Therapeutics |
| XOMA |
Ovid Therapeutics and XOMA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ovid Therapeutics and XOMA
The main advantage of trading using opposite Ovid Therapeutics and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ovid Therapeutics position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.| Ovid Therapeutics vs. CytomX Therapeutics | Ovid Therapeutics vs. Spero Therapeutics | Ovid Therapeutics vs. Instil Bio | Ovid Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |